NCT00103233View on ClinicalTrials.gov

Vinorelbine With or Without Trastuzumab in Treating Women With Progressive Metastatic Breast Cancer

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 2004

Study Completion Date

April 30, 2006

Conditions
Breast Cancer
Interventions
BIOLOGICAL

trastuzumab

DRUG

vinorelbine tartrate

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

SWOG Cancer Research Network

NETWORK

NCT00103233 - Vinorelbine With or Without Trastuzumab in Treating Women With Progressive Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter